Complete transgene integration site characterization for producer cell banks and immunotherapy products with TLA technology
In this webinar, recorded November 12 2020, we present the advantages of TLA in both the upstream and downstream processes of cell and gene therapy manufacturing.
The following subjects are highlighted:
- Principles of TLA technology
- Viral vector producing MCB characterization
- Characterization of immunotherapy products
For an overview of the publications cited in the presentation, click here for cell and gene therapy.
Please contact us for more information.